Application of LAMP coupled with NALF for precise detection of mycoplasma pneumoniae

Qi Yun1, Si Fei Ma2, Yue Cui1

  • 1Changzhou Children's Hospital Affiliated to Nantong University, Changzhou, Jiangsu Province, 213003, China.

Insights

A new Mycoplasma pneumoniae (MP) test combines loop-mediated isothermal amplification (LAMP) and nucleic acid lateral flow (NALF) for rapid, visual detection. This MP-LAMP-NALF assay offers high accuracy and speed, improving diagnosis for children.

Area of Science:

  • Microbiology
  • Molecular Diagnostics
  • Pediatric Infectious Diseases

Background:

  • Mycoplasma pneumoniae (MP) is a leading cause of community-acquired pneumonia in children.
  • Current diagnostic methods for MP infection lack speed, ease of use, and accuracy, hindering clinical diagnosis.
  • There is a need for accessible and reliable laboratory testing for MP.

Purpose of the Study:

  • To develop and evaluate a rapid, visual, and accurate diagnostic assay for Mycoplasma pneumoniae.
  • To utilize loop-mediated isothermal amplification (LAMP) combined with nucleic acid lateral flow (NALF) for MP detection.
  • To assess the sensitivity, specificity, and performance of the developed MP-LAMP-NALF assay.

Main Methods:

  • Loop-mediated isothermal amplification (LAMP) was used to amplify the P1 gene of Mycoplasma pneumoniae.
  • Nucleic acid lateral flow (NALF) was employed for visual detection of the amplified MP DNA.
  • The MP-LAMP-NALF assay's limit of detection, specificity, and concordance with quantitative real-time PCR were evaluated.

Main Results:

  • The MP-LAMP-NALF assay demonstrated a limit of detection as low as 100 copies per reaction.
  • No cross-reactivity was observed with other common respiratory pathogens.
  • The assay achieved a 94.3% concordance rate with quantitative real-time PCR, with a turnaround time of approximately 50 minutes.

Conclusions:

  • The MP-LAMP-NALF assay is a simple, precise, and visual method for detecting Mycoplasma pneumoniae.
  • This assay can be widely implemented in various clinical settings, including outpatient, emergency, and primary care facilities.
  • Further optimization could enable its use as a point-of-care test for pathogen detection.